PARLIAMENTARY WRITTEN QUESTION
(12 February 2026)
Question Asked
Asked by:
Helen Morgan (Liberal Democrat)
Answer
The following table shows the nominal and real terms funding provided through the Community Pharmacy Contractual Framework each year since 2015/16:
| Nominal value (£m) | Gross domestic product deflator at December 2025 | Real terms value 2025/26 prices (£m) |
2015/16 | 2,800 | 72.46 | 3,864 |
2016/17 | 2,687 | 73.91 | 3,636 |
2017/18 | 2,592 | 74.85 | 3,463 |
2018/19 | 2,592 | 76.55 | 3,386 |
2019/20 | 2,592 | 78.57 | 3,299 |
2020/21 | 2,592 | 82.68 | 3,135 |
2021/22 | 2,592 | 82.87 | 3,128 |
2022/23 | 2,592 | 88.70 | 2,922 |
2023/24 | 2,592 | 93.38 | 2,776 |
2024/25 | 2,698 | 97.14 | 2,777 |
2025/26 | 3,073 | 100.00 | 3,073 |
In 2025/26, the funding for the core community pharmacy contractual framework was increased to £3.1 billion. This represented the largest uplift in funding of any part of the National Health Service at the time, over 19% across 2024/25 and 2025/26. Additional funding was also made available, for example, for pharmacies delivering Pharmacy First consultations and flu and COVID-19 vaccinations.
Answered by:
()
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.